Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2

The exploration and identification of safe and effective vaccines for the SARS-CoV-2 pandemic have captured the world's attention and remains an ongoing issue due to concerns of balancing protection against emerging variants of concern while also generating long-lasting immunity. Here, we repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Runqiang, Xie, Hui, Khorsandzadeh, Sahba, Smith, Madison, Shaabani, Namir, Hu, Qidong, Lyu, Xiaoxuan, Wang, Hua, Lim, Wan-lin, Sun, Haotian, Ji, Henry, Cooley, Brian, Ross, Russell, Francis, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753907/
https://www.ncbi.nlm.nih.gov/pubmed/35803578
http://dx.doi.org/10.1093/jmcb/mjac041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753907/
https://www.ncbi.nlm.nih.gov/pubmed/35803578
http://dx.doi.org/10.1093/jmcb/mjac041

Ejemplares similares